vs
Side-by-side financial comparison of Ranpak Holdings Corp. (PACK) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $93.7M, roughly 1.8× Ranpak Holdings Corp.). On growth, Ranpak Holdings Corp. posted the faster year-over-year revenue change (2.3% vs -22.7%). Over the past eight quarters, Ranpak Holdings Corp.'s revenue compounded faster (13.7% CAGR vs -11.5%).
Ranpak Holdings Corp. manufactures machines and paper products used in protective paper-based packing for shipping goods and merchandise for e-commerce and industry, along with automation solutions. The company is based in Concord, Ohio, and has production facilities and offices in Reno, Nevada; Kansas City, Missouri; the Netherlands; Czech Republic; Shanghai and Singapore. The paper packaging material can be used for multiple applications like wrapping, cushioning, void fill and cold chain p...
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
PACK vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $93.7M | $164.7M |
| Net Profit | — | $-135.0M |
| Gross Margin | 39.0% | — |
| Operating Margin | -1.0% | -43.3% |
| Net Margin | — | -82.0% |
| Revenue YoY | 2.3% | -22.7% |
| Net Profit YoY | — | -104.8% |
| EPS (diluted) | $-0.11 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $93.7M | $164.7M | ||
| Q3 25 | $83.6M | $211.0M | ||
| Q2 25 | $77.8M | $178.9M | ||
| Q1 25 | $77.6M | $1.2B | ||
| Q4 24 | $91.6M | $213.2M | ||
| Q3 24 | $78.6M | $196.8M | ||
| Q2 24 | $72.8M | $186.7M | ||
| Q1 24 | $72.5M | $210.1M |
| Q4 25 | — | $-135.0M | ||
| Q3 25 | $-10.4M | $15.9M | ||
| Q2 25 | $-7.5M | $-64.8M | ||
| Q1 25 | $-10.9M | $866.6M | ||
| Q4 24 | — | $-65.9M | ||
| Q3 24 | $-8.1M | $-106.7M | ||
| Q2 24 | $5.5M | $-99.2M | ||
| Q1 24 | $-8.1M | $-91.6M |
| Q4 25 | 39.0% | — | ||
| Q3 25 | 41.1% | — | ||
| Q2 25 | 37.1% | — | ||
| Q1 25 | 39.8% | — | ||
| Q4 24 | 45.2% | — | ||
| Q3 24 | 43.8% | — | ||
| Q2 24 | 43.5% | — | ||
| Q1 24 | 44.6% | — |
| Q4 25 | -1.0% | -43.3% | ||
| Q3 25 | -6.8% | 1.4% | ||
| Q2 25 | -12.5% | -19.5% | ||
| Q1 25 | -10.3% | 82.5% | ||
| Q4 24 | 1.5% | -76.2% | ||
| Q3 24 | -5.3% | -27.7% | ||
| Q2 24 | -7.1% | -21.5% | ||
| Q1 24 | -6.6% | -21.6% |
| Q4 25 | — | -82.0% | ||
| Q3 25 | -12.4% | 7.5% | ||
| Q2 25 | -9.6% | -36.3% | ||
| Q1 25 | -14.0% | 73.7% | ||
| Q4 24 | — | -30.9% | ||
| Q3 24 | -10.3% | -54.2% | ||
| Q2 24 | 7.6% | -53.1% | ||
| Q1 24 | -11.2% | -43.6% |
| Q4 25 | $-0.11 | $-1.63 | ||
| Q3 25 | $-0.12 | $0.20 | ||
| Q2 25 | $-0.09 | $-0.83 | ||
| Q1 25 | $-0.13 | $10.04 | ||
| Q4 24 | $-0.13 | $-0.85 | ||
| Q3 24 | $-0.10 | $-1.39 | ||
| Q2 24 | $0.07 | $-1.29 | ||
| Q1 24 | $-0.10 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $63.0M | $1.9B |
| Total DebtLower is stronger | $401.9M | — |
| Stockholders' EquityBook value | $534.9M | $-205.3M |
| Total Assets | $1.1B | $2.9B |
| Debt / EquityLower = less leverage | 0.75× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.0M | $1.9B | ||
| Q3 25 | $49.9M | $1.7B | ||
| Q2 25 | $49.2M | $2.0B | ||
| Q1 25 | $65.5M | $2.0B | ||
| Q4 24 | $76.1M | $1.1B | ||
| Q3 24 | $69.5M | $1.0B | ||
| Q2 24 | $65.1M | $1.1B | ||
| Q1 24 | $55.1M | $884.8M |
| Q4 25 | $401.9M | — | ||
| Q3 25 | $403.1M | — | ||
| Q2 25 | $403.1M | — | ||
| Q1 25 | $405.2M | — | ||
| Q4 24 | $406.4M | — | ||
| Q3 24 | $403.2M | — | ||
| Q2 24 | $396.1M | — | ||
| Q1 24 | $396.7M | — |
| Q4 25 | $534.9M | $-205.3M | ||
| Q3 25 | $537.8M | $-155.8M | ||
| Q2 25 | $539.0M | $-206.5M | ||
| Q1 25 | $544.1M | $-185.8M | ||
| Q4 24 | $548.1M | $-1.1B | ||
| Q3 24 | $564.3M | $-1.1B | ||
| Q2 24 | $566.2M | $-980.2M | ||
| Q1 24 | $560.0M | $-893.9M |
| Q4 25 | $1.1B | $2.9B | ||
| Q3 25 | $1.1B | $2.6B | ||
| Q2 25 | $1.1B | $2.6B | ||
| Q1 25 | $1.1B | $2.7B | ||
| Q4 24 | $1.1B | $1.7B | ||
| Q3 24 | $1.1B | $1.8B | ||
| Q2 24 | $1.1B | $1.9B | ||
| Q1 24 | $1.1B | $1.8B |
| Q4 25 | 0.75× | — | ||
| Q3 25 | 0.75× | — | ||
| Q2 25 | 0.75× | — | ||
| Q1 25 | 0.74× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 0.71× | — | ||
| Q2 24 | 0.70× | — | ||
| Q1 24 | 0.71× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $19.5M | $-34.3M |
| Free Cash FlowOCF − Capex | — | $-36.6M |
| FCF MarginFCF / Revenue | — | -22.3% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.5M | $-34.3M | ||
| Q3 25 | $8.5M | $-66.3M | ||
| Q2 25 | $-3.6M | $-58.3M | ||
| Q1 25 | $-1.3M | $870.1M | ||
| Q4 24 | $6.5M | $-30.0M | ||
| Q3 24 | $10.1M | $-77.0M | ||
| Q2 24 | $19.6M | $-71.5M | ||
| Q1 24 | $5.2M | $70.8M |
| Q4 25 | — | $-36.6M | ||
| Q3 25 | — | $-69.7M | ||
| Q2 25 | — | $-59.6M | ||
| Q1 25 | — | $868.4M | ||
| Q4 24 | — | $-33.8M | ||
| Q3 24 | — | $-77.5M | ||
| Q2 24 | — | $-78.8M | ||
| Q1 24 | — | $61.2M |
| Q4 25 | — | -22.3% | ||
| Q3 25 | — | -33.1% | ||
| Q2 25 | — | -33.3% | ||
| Q1 25 | — | 73.8% | ||
| Q4 24 | — | -15.8% | ||
| Q3 24 | — | -39.4% | ||
| Q2 24 | — | -42.2% | ||
| Q1 24 | — | 29.1% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 4.0% | ||
| Q1 24 | — | 4.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | -4.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 3.56× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PACK
| Other | $47.9M | 51% |
| Europe And Asia Segment | $45.8M | 49% |
PTCT
Segment breakdown not available.
